Microglia is an Active Player in How Glibenclamide Improves Stroke Outcome | Zendy

Francisco J. Ortega | Zendy; Jukka Jolkkonen | Zendy; Manuel J. Rodrı́guez | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Microglia is an Active Player in How Glibenclamide Improves Stroke Outcome

Author(s) -

Francisco J. Ortega,

Jukka Jolkkonen,

Manuel J. Rodrı́guez

Publication year - 2013

Publication title -

journal of cerebral blood flow and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.167

H-Index - 193

eISSN - 1559-7016

pISSN - 0271-678X

DOI - 10.1038/jcbfm.2013.72

Subject(s) - glibenclamide , microglia , sulfonylurea receptor , medicine , ischemia , potassium channel , neuroscience , blockade , pharmacology , stroke (engine) , receptor , inflammation , endocrinology , biology , diabetes mellitus , mechanical engineering , engineering

The recent review article"Sulfonylurea receptor 1 in central nervous system injury: a focused review"1 is an extensive summary of the current knowledge of the role of the sulfonylurea receptor 1 (SUR-1) and SUR-1-regulated NCCa-ATP channels in acute brain injuries. The review also highlights the potential translational applicability of the use of glibenclamide in treating brain pathologies such as cerebral ischemia or traumatic brain injury

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research